These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 15577681

  • 21. Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression.
    Samaratunga H, Makarov DV, Epstein JI.
    Urology; 2002 Aug; 60(2):315-9. PubMed ID: 12137833
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Glucose transporter-1 expression in urothelial papilloma of the bladder.
    Lee JH, Kim YW, Chang SG.
    Urol Int; 2005 Aug; 74(3):268-71. PubMed ID: 15812216
    [Abstract] [Full Text] [Related]

  • 24. Flat intraepithelial lesions of the urinary bladder.
    Cheng L, Cheville JC, Neumann RM, Bostwick DG.
    Cancer; 2000 Feb 01; 88(3):625-31. PubMed ID: 10649257
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
    Pan CC, Chang YH, Chen KK, Yu HJ, Sun CH, Ho DM.
    Am J Clin Pathol; 2010 May 01; 133(5):788-95. PubMed ID: 20395527
    [Abstract] [Full Text] [Related]

  • 27. Diagnostic difficulties in cases of papillary urothelial neoplasm of low malignant potential, urothelial proliferation of uncertain malignant potential, urothelial dysplasia and urothelial papilloma: A review of current literature.
    Jaworski D, Szylberg Ł, Gzil A, Stawinski P, Kasperska A, Marszałek A.
    Ann Diagn Pathol; 2019 Jun 01; 40():182-188. PubMed ID: 29395466
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Urothelial tumors of the urinary bladder in young patients: a clinicopathologic study of 59 cases.
    Stanton ML, Xiao L, Czerniak BA, Guo CC.
    Arch Pathol Lab Med; 2013 Oct 01; 137(10):1337-41. PubMed ID: 24079760
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Noninvasive low-grade papillary urothelial carcinoma with degenerative nuclear atypia: a grading pitfall.
    Matoso A, Parimi V, Epstein JI.
    Hum Pathol; 2021 Jul 01; 113():1-8. PubMed ID: 33887303
    [Abstract] [Full Text] [Related]

  • 32. [New WHO classification of urothelial carcinoma of the urinary bladder].
    Helpap B.
    Verh Dtsch Ges Pathol; 2002 Jul 01; 86():57-66. PubMed ID: 12647352
    [Abstract] [Full Text] [Related]

  • 33. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.
    Curry JL, Wojcik EM.
    Cancer; 2002 Jun 25; 96(3):140-5. PubMed ID: 12115301
    [Abstract] [Full Text] [Related]

  • 34. Frequent FGFR3 mutations in urothelial papilloma.
    van Rhijn BW, Montironi R, Zwarthoff EC, Jöbsis AC, van der Kwast TH.
    J Pathol; 2002 Oct 25; 198(2):245-51. PubMed ID: 12237885
    [Abstract] [Full Text] [Related]

  • 35. Expression of cytokeratin 20 redefines urothelial papillomas of the bladder.
    Harnden P, Mahmood N, Southgate J.
    Lancet; 1999 Mar 20; 353(9157):974-7. PubMed ID: 10459907
    [Abstract] [Full Text] [Related]

  • 36. Urothelial Proliferation of Unknown Malignant Potential Involving the Bladder: Histopathologic Features and Risk of Progression in De Novo Cases and Cases With Prior Neoplasia.
    Lowenthal BM, Sahoo D, Amin MB, Hansel DE.
    Arch Pathol Lab Med; 2020 Jul 01; 144(7):853-862. PubMed ID: 31825667
    [Abstract] [Full Text] [Related]

  • 37. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?
    Cheville JC, Wu K, Sebo TJ, Cheng L, Riehle D, Lohse CM, Shane V.
    Cancer; 2000 Feb 01; 88(3):632-6. PubMed ID: 10649258
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
    Fine SW, Humphrey PA, Dehner LP, Amin MB, Epstein JI.
    J Urol; 2005 Nov 01; 174(5):1976-80. PubMed ID: 16217372
    [Abstract] [Full Text] [Related]

  • 40. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
    Alsheikh A, Mohamedali Z, Jones E, Masterson J, Gilks CB.
    Mod Pathol; 2001 Apr 01; 14(4):267-72. PubMed ID: 11301341
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.